The application of weighted gene co-expression network analysis shows a possible influence of RACGAP1 expression on the pathological T stage, histologic grade and cellular proliferation of HCC, implying that RACGAP1 can be a prognostic factor or treatment target for HCC [12]. This evidence concerns the gene RACGAP1 and hepatocellular carcinoma.